169248 ⎘
Investigating or analysing materials by specific methods not covered by groups -; Biological material, e.g. blood, urine ; Haemocytometers; Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing; Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses; Animal cells White blood cells
Activation-dependent immune dysfunction traits enable identification of prodromal Parkinson's
#2BIOMARKER BASED STANDARDS AND METHODS OF USE
#3CONTROL CELL POPULATIONS FOR DETECTION OF PAROXYSMAL NOCTURNAL HEMOGLOBINURIA
#4Uses of Siglec-9 ECD Fusion Molecules in Cancer Treatment
#5METHODS FOR MEASURING LYMPHOCYTE ACTIVITY
#6MEANS AND METHODS FOR ANTIBODY DISCOVERY
#7Molecular Tension Probes and Methods to Determine or Monitor the Efficacy of Cancer and Other Immune Therapies
#8DIAGNOSIS, PROGNOSIS AND THERAPY OF NEUROINFLAMMATORY AUTOIMMUNE DISEASES USING CELLULAR AND SOLUBLE BLOOD PARAMETERS
#9METHODS OF DETECTING IMMUNE CELLS
#10CD127 EXPRESSION INVERSELY CORRELATES WITH FOXP3 AND SUPPRESSIVE FUNCTION OF CD4+ TREGS
#11Improved monocyte activation test
#12PREVENTION AND TREATMENT OF CYTOKINE RELEASE SYNDROME AND NEUROTOXICITY ASSOCIATED WITH CAR-T CELL THERAPY
#13ADULT STEM CELL COMPOSITIONS AND METHODS OF IDENTIFICATION AND ISOLATION
#14TWO-DIMENSIONAL AND NANO-MATERIALS AS MASS TAGS AND CELL LABELING SYSTEMS IN MASS CYTOMETRY AND HIGH-DIMENSIONAL IMAGING
#15ANTI-CCR8 ANTIBODIES AND USES THEREOF
#16METHOD FOR GENERATING HIGH AFFINITY ANTIBODIES
#17COMPOSITIONS AND METHODS FOR THE TREATMENT OF IMMUNE RELATED DISEASES
#18COMPOSITIONS AND METHODS FOR PLASMAPHERESIS
#19COMPOSITIONS AND METHODS FOR PLASMAPHERESIS
#20ALPHAVIRUS T CELL EPITOPES, MEGAPOOLS AND USES THEREOF
#21BIOMARKERS, DIAGNOSTIC METHODS, TREATMENTS, AND THERAPEUTICS FOR AUTOIMMUNE DISORDERS AND DISEASES
#22COMBINATION THERAPY WITH ANTI-PVRIG ANTIBODIES FORMULATIONS AND ANTI-PD-1 ANTIBODIES
#23GAS-FILLED MICROVESICLES WITH LIGAND
#24PREFERENTIAL DEPLETION OF TCF1+ PROGENITOR T-CELLS IN SEVERE COVID-19 AS MEDIATED BY INTERLEUKIN 12 (IL-12)
#25METHOD FOR MONITORING AND EVALUATION OF BOWEL HEALTH IN PREMATURE NEWBORNS
#26CANCER ANTIGEN TARGETS AND USES THEREOF
#27THERAPEUTIC AND DIAGNOSTIC METHODS FOR MULTIPLE MYELOMA
#28IDENTIFYING PATIENT RESPONSE TO S1P RECEPTOR MODULATOR ADMINISTRATION
#29METHODS FOR ISOLATING, CULTURING, AND GENETICALLY ENGINEERING IMMUNE CELL POPULATIONS FOR ADOPTIVE THERAPY
#30COMPOSITIONS AND METHODS FOR PLASMAPHERESIS
#31COMPOSITIONS AND METHODS FOR PLASMAPHERESIS
#32METHODS AND COMPOSITIONS RELATING TO MOUSE MONOCLONAL ANTI-G4S LINKER ANTIBODIES
#33NOVEL BIOMARKER TO PREDICT EFFICACY OF CANCER IMMUNOTHERAPY
#34Assessment of immune cells in the uterine fluid at the time of the embryo transfer
#35COMPOSITIONS AND METHODS COMPRISING ANTIBODIES THAT BIND TO COVALENT PEPTIDE CONJUGATES
#36METHODS AND COMPOSITIONS FOR TREATING GLIOMAS
#37METHOD OF DETERMINING THE PRESENCE AND/OR AMOUNT OF TARGET MOLECULES
#38T Cell Receptor Identification
#39ENDOGENOUS SIGNALING MOLECULE ACTIVATING CHIMERIC ANTIGEN RECEPTORS AND METHODS OF GENERATION THEREOF
#40CYTOMEGALOVIRUS T CELL EPITOPES AND USES THEREOF
#41Polymer Composite Nanomaterial Encapsulation System
#42LIQUID BIOPSY FOR DIAGNOSIS OF EARLY OSTEOARTHRITIS
#43DETECTION OF ANTI-VIRAL CDR3s IN NEUROBLASTOMA
#44METHOD FOR CLASSIFYING CELLS
#45METHODS FOR GENERATING HIGH AFFINITY ANTIBODIES AGAINST FENTANYL
#46COMPOSITIONS AND METHODS FOR TREATING AND/OR CHARACTERIZING HEMATOLOGICAL MALIGNANCIES AND PRECURSOR CONDITIONS
#47Compositions and Methods for NK-92 Cells Expressing Native CD16
#48COMPOSITIONS AND METHODS FOR MODULATING IMMUNE RESPONSES
#49UNDER-OIL EXTRACTION USING EXCLUSIVE LIQUID REPELLENCY FOR CELL ISOLATION
#50METHODS AND SYSTEMS FOR PREDICTING SINGLE CELL TRANSCRIPTOMIC INFORMATION FROM FLOW CYTOMETRY DATA
#51PEPTIDES AND ENGINEERED T CELL RECEPTORS TARGETING NDC80 ANTIGEN AND METHODS OF USE
#52SAMPLE PREPARATION INSTRUMENT
#53METHODS OF DETERMINING PROGNOSIS OF SEPSIS AND TREATING SAME
#54METHODS OF DETERMINING A HEALTH STATUS OF A DOG BASED ON ONE OR MORE BIOMARKERS, AND METHODS OF TREATING A MORTALITY RISK IDENTIFIED BY THE HEALTH STATUS
#55METHODS OF DETERMINING A HEALTH STATUS OF A CAT BASED ON ONE OR MORE BIOMARKERS, AND METHODS OF TREATING A MORTALITY RISK IDENTIFIED BY THE HEALTH STATUS
#56METHOD FOR PREDICTING PROGNOSIS AND RESPONSIVENESS TO ANTICANCER THERAPY OF CANCER PATIENTS
#57ASSAY FOR T CELL DEPENDENT MULTISPECIFIC COMPOUNDS
#58GENE USING BCMA EXTRACELLULAR DOMAIN AS MARKER, POLYPEPTIDE, RECOMBINANT EXPRESSION VECTOR, GENETICALLY ENGINEERED CELL, AND USE THEREOF
#59ANTI-TUMOUR RESPONSES TO CYTOKERATINS
#60ESTIMATING CELLULAR POPULATIONS
#61Proteins and T-Cells Involved in Chronic Inflammatory Diseases
#62METHOD FOR PERFORMING EARLY DIAGNOSIS OF SEPSIS USING ANALYSIS DEVICE INCLUDING MICRO FILTER
#63METHODS FOR PRODUCING GENETICALLY ENGINEERED CELL COMPOSITIONS AND RELATED COMPOSITIONS
#64PRAME IMMUNOGENIC PEPTIDES, BINDING PROTEINS RECOGNIZING PRAME IMMUNOGENIC PEPTIDES, AND USES THEREOF
#65ANTIGEN BINDING MOLECULES AND METHODS OF USE THEREOF
#66Diabetes Biomarkers
#67CD4+ T CELL MARKERS, COMPOSITIONS, AND METHODS FOR CANCER
#68COUPLING ASSAY FOR T CELL SPECIFICITY (CATS) AND METHOD OF ITS USE
#69Coronavirus T Cell Epitopes, Megapools and Uses Thereof
#70DEVICE AND METHOD FOR ISOLATION AND DETECTION OF TARGETS IN A SAMPLE
#71TRUNCATED DOMAIN IV EGFR AND USES THEREOF
#72GASDERMIN E EXPRESSION IN HUMAN T CELLS AS A MARKER FOR PROINFLAMMATORY T CELL FUNCTIONS
#73Biomarkers for Neurodegenerative Disease
#74ACCURATE ENUMERATION OF LEUKOCYTE SUBSETS IN PERIPHERAL BLOOD WITH A 15-COLOR IMMUNOPROFILING PANEL USING A SPECTRAL FLOW CYTOMETER
#75ANTI-BCMA CAR ANTIBODIES, CONJUGATES, AND METHODS OF USE
#76METHODS AND MATERIALS FOR THE DETECTION OF LATENT TUBERCULOSIS INFECTION
#77BOOSTED IMMUNE MONITORING METHODS FOR ASSAYING ANTIGEN-SPECIFIC T CELL RESPONSES
#78Liquid Biopsy Analysis of Cellular States to Predict Immunotherapy Toxicity
#79METHODS AND MATERIALS FOR INHIBITING/PREVENTING THE TRAFFICKING OF MONOCYTES TO THE CENTRAL NERVOUS SYSTEM
#80USE OF CD38+HLA-DR+CD8+ T CELL IN EARLY DIAGNOSIS OF ACUTE GRAFT-VERSUS-HOST DISEASE
#81MEANS AND METHODS FOR IDENTIFYING HIGH AFFINITY T-CELLS
#82PEPTIDE-MHC COMPACTS
#83CD206 Targeted Peptide Conjugates and Methods of Using the Same
#84METHODS FOR ISOLATING, CULTURING, AND GENETICALLY ENGINEERING IMMUNE CELL POPULATIONS FOR ADOPTIVE THERAPY
#85METHODS FOR ISOLATING, CULTURING, AND GENETICALLY ENGINEERING IMMUNE CELL POPULATIONS FOR ADOPTIVE THERAPY
#86SYSTEM, METHOD, AND ARTICLE FOR DETECTING ABNORMAL CELLS USING MULTI-DIMENSIONAL ANALYSIS
#87CYCLIC PEPTIDE FOR CANCER IMMUNOTHERAPY
#88METHODS FOR ISOLATING, CULTURING, AND GENETICALLY ENGINEERING IMMUNE CELL POPULATIONS FOR ADOPTIVE THERAPY
#89SERS NANO-PARTICLE, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF TO METHOD FOR DISTINGUISHING CTCS FROM WBCS
#90PEPTIDE
#91METHODS FOR IDENTIFYING AND USING ALLOGENEIC TUMOR INFILTRATING LYMPHOCYTES TO TREAT CANCER
#92METHODS FOR THE DETECTION AND QUANTIFICATION OF CIRCULATING TUMOR CELL MIMICS
#93COMPOSITIONS AND METHODS FOR TREATING CORONAVIRUS INFECTIOUS DISEASE-19 (COVID-19)
#94METHODS OF ANALYZING A SAMPLE FOR CANCER-SPECIFIC IMMUNE CELLS
#95Methods for isolating, culturing, and genetically engineering immune cell populations for adoptive therapy
#96COMPOSITIONS AND METHODS FOR THE PREVENTION AND TREATMENT OF AUTOIMMUNE CONDITIONS
#97ANALYSIS SYSTEM AND METHOD OF ANALYSIS
#98METHODS OF DETECTING DISEASES OR CONDITIONS USING PHAGOCYTIC CELLS
#99METHOD AND SYSTEM FOR BUOYANT-PARTICLE-ASSISTED CELL THERAPY
#100USE OF AMINO ACID SEQUENCES FROM MYCOBACTERIUM TUBERCULOSIS OR CORRESPONDING NUCLEIC ACIDS FOR DIAGNOSIS AND PREVENTION OF TUBERCULAR INFECTION, DIAGNOSTIC KIT AND VACCINE THEREFROM
#101TREATMENT OF AUTOIMMUNE DISEASES WITH ENGINEERED IMMUNE CELLS
#102COMPOSITIONS AND METHODS FOR CHARACTERIZING ANTIGEN BINDING MOLECULES FROM SINGLE CELLS
#103PERFORMING MEASUREMENTS ON A SAMPLE
#104STATISTICAL ANALYSIS OF THE OVARIAN TUMOR IMMUNE MICROENVIRONMENT USING MULTIPLEX IMMUNOFLUORESCENCE
#105METHODS FOR IDENTIFYING RECEPTORS AND CELLULAR AVIDITIES
#106METHODS AND SYSTEMS FOR ASSESSING IMMUNE CELL RECEPTORS AND ANTIGENS
#107COMPOSITIONS AND METHODS FOR DIAGNOSING AUTOIMMUNE AQUAPORINOPATHY
#108METHOD FOR DETERMINING BASOPHIL ACTIVATION IN A SAMPLE
#109METHODS AND RELATED ASPECTS FOR DETECTING AND QUANTIFYING CHIMERIC ANTIGEN RECEPTOR T CELLS IN SAMPLES
#110METHODS OF ASSAYING MICRO-OBJECTS IN A MICROFLUIDIC DEVICE
#111METHODS FOR DETECTING DYSFUNCTIONAL NK CELLS IN LEUKEMIA PATIENTS
#112METHODS AND MATERIALS FOR ASSESSING IMMUNE SYSTEM PROFILES
#113METHODS, COMPOSITIONS AND SYSTEMS FOR USING POOLED DONOR SAMPLES FOR LABORATORY TESTING
#114CHROMATOGRAPHIC ISOLATION OF CELLS AND OTHER COMPLEX BIOLOGICAL MATERIALS
#115METHODS FOR DEFINING STAGES AND PROGRESSION OF AMYOTROPHIC LATERAL SCLEROSIS
#116DYSFUNCTIONAL ANTIGEN-SPECIFIC CD8+ T CELLS IN THE TUMOR MICROENVIRONMENT
#117TRUNCATED DOMAIN IV EGFR AND USES THEREOF
#118IDENTIFICATION AND USES OF PEPTIDE SEQUENCES OF SARS-COV-2 T CELL AND B CELL EPITOPES
#119METHOD OF DETERMINING SEPSIS IN THE PRESENCE OF BLAST FLAGGING
#120ANTI-PD1 THERAPY BASED ON RESPONSE TO IFN-I STIMULATION
#121METHOD AND KIT FOR IMMUNOTYPING OF T LYMPHOCYTE DEVELOPMENT SUBGROUPS
#122NOVEL COMPOSITIONS AND METHODS FOR THE TREATMENT OF IMMUNE RELATED DISEASES
#123METHODS, REAGENTS AND KITS FOR FLOW CYTOMETRIC IMMUNOPHENOTYPING
#124IgE+ PLASMABLASTS AS A PREDICTIVE BIOMARKER OF ALLERGY
#125Compositions and methods for plasmapheresis
#126ANTIBODY BINDING TO LINKER OF scFv OR LIKE
#127Method for Magnetically Sorting Biological Objects
#128METHODS FOR DETECTING HEAVY METALS IN BIOLOGICAL SAMPLES
#129HERV-K ANTIBODY THERAPEUTICS
#130METHOD OF EVALUATING PROGRESSION OF AN INFECTIOUS DISEASE AND/OR INFLAMMATORY DISEASE
#131APPLICATION OF MULTIMER IN DETECTION AND PREPARATION OF CAR-EXPRESSING CELL
#132ON-BOARD CONJUGATION
#133COSTIMULATORY B7-H1 IN RENAL CELL CARCINOMA PATIENTS: INDICATOR OF TUMOR AGGRESSIVENESS AND POTENTIAL THERAPEUTIC TARGET
#134ANTI-TIGIT ANTIBODY AND USE THEREOF
#135REAGENTS, METHODS AND KITS FOR DIAGNOSING PRIMARY IMMUNODEFICIENCIES
#136A METHOD OF DETECTING A POPULATION OF MACROPHAGES
#137METHODS FOR OBTAINING ANTIBODY MOLECULES WITH HIGH AFFINITY
#138Method of Treating Liver Cancer, Predicting Response to Treatment, and Predicting Adverse Effects During the Treatment Thereof
#139MICRODEVICE FOR CELL SEPARATION UTILIZING ACTIVATION PHENOTYPE
#140METHOD FOR STRATIFICATION AND TREATMENT OF MULTIPLE SCLEROSIS
#141COMPOSITIONS AND METHODS FOR DETECTING PROSTATE CANCER
#142COMPOSITIONS AND METHODS FOR TREATING DRY EYE
#143METHODS FOR PREDICTING MULTI-ORGAN METASTATIC DISEASE AND OVERALL AND PROGRESSION FREE SURVIVAL IN SUBJECTS HAVING HYPER-ENGORGED CIRCULATING CANCER ASSOCIATED MACROPHAGE-LIKE CELLS (CAMLS)
#144BIOPARTICLE ANALYSIS METHOD AND REAGENT KIT FOR BIOPARTICLE ANALYSIS
#145DIAGNOSTICS AND THERAPEUTICS FOR EBV IN MS AND OTHER AUTOIMMUNE DISEASES
#146COMBINATION THERAPY FOR CANCER
#147MIGRATION OF HUMAN PERIPHERAL LEUKOCYTES IN RESPONSE TO CHEMOTACTIC FACTORS DURING PREGNACY
#148TGF-BETA INHIBITORS AND THERAPEUTIC USE THEREOF
#149NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS
#150IMMUNOSTIMULATORY BACTERIA FOR CONVERTING MACROPHAGES INTO A PHENOTYPE AMENABLE TO TREATMENT, AND COMPANION DIAGNOSTIC FOR IDENTIFYING SUBJECTS FOR TREATMENT
#151PEPTIDES AND ENGINEERED T CELL RECEPTORS TARGETING SARS-COV-2 ANTIGENS AND METHODS OF USE
#152SELECTION OF PATIENTS FOR COMBINATION THERAPY
#153LABELING BIOLOGICAL PARTICLES USING ACOUSTOPHORESIS
#154Compositions and methods for plasmapheresis
#155Compositions and methods for plasmapheresis
#156Individualized Cell Therapy Using Patient-Derived Antigen-Specific Regulatory T Cells
#157Suppressive T Cell Populations and Methods of Cancer Immunotherapy
#158IDENTIFYING PATIENT RESPONSE TO S1P RECEPTOR MODULATOR ADMINISTRATION
#159BIOMARKER FOR PREDICTING RESPONSE TO CANCER TREATMENT
#160TOLEROGENIC SYNTHETIC NANOCARRIERS FOR ALLERGY THERAPY
#161PERIVASCULAR ACCUMULATION OF IMMUNE CELLS IN THE DIAGNOSIS AND TREATMENT OF CANCER
#162PREDICTION OF STEM CELL THERAPY RESPONSIVENESS BY QUANTIFICATION OF PRE-EXISTING B REGULATORY CELLS
#163NEUROPROTECTIVE COMPOSITIONS AND METHODS
#164HIGHLY SENSITIVE AND SPECIFIC LUCIFERASE BASED REPORTER ASSAY FOR ANTIGEN DETECTION
#165CD70 ANTI-IDIOTYPE ANTIBODIES
#166BONE MARROW ASPIRATE ANALYSIS METHOD, SAMPLE ANALYZER, AND COMPUTER PROGRAM
#167HIGH PARAMETER FLOW CYTOMETRIC ASSAY TO IDENTIFY HUMAN MYELOID DERIVED SUPPRESSIVE CELLS
#168BATCH RELEASE ASSAY FOR PHARMACEUTICAL PRODUCTS RELATING TO T CELL THERAPIES
#169METHODS FOR TREATING CANCER USING ANTI-CTLA4 ANTIBODIES
#170NOVEL SINGLE DOMAIN ANTIGEN BINDING MOLECULES AND THEIR USES
#171FOLR2+ MACROPHAGES AND ANTI-TUMOR IMMUNITY
#172A 3-LASER 13-COLOR B CELL MONITORING PANEL AND REAGENT KIT FOR ANALYZING B CELL SUBSETS IN ANTI-CD20 TREATED AUTOIMMUNE PATIENTS
#173Method of Tracking Maintenance of Immunological Tolerance
#174MARKERS OF AUTOIMMUNE DISEASES
#175SYSTEMS AND METHODS FOR COMPREHENSIVE AND STANDARDIZED IMMUNE SYSTEM PHENOTYPING AND AUTOMATED CELL CLASSIFICATION
#176CLASSIFICATION OF NEUROLOGICAL OR PSYCHIATRIC DISEASE MANIFESTATIONS USING MULTI-DIMENSIONAL CEREBROSPINAL FLUID ANALYSIS
#177Method and Apparatus for Magnetically Sorting Rare Cells
#178HIGH PARAMETER 20 COLOR PANEL FOR EFFECTIVE DETECTION OF ABERRANT CELLS IN ACUTE MYELOID LEUKEMIA
#179METHOD OF SELECTING CELLS
#180TOLEROGENIC SYNTHETIC NANOCARRIERS
#181LUNG-CANCER SPECIFIC T CELL DYSFUNCTION
#182METHODS OF PREDICTING AND TREATING IMMUNOTHERAPY TOXICITY BASED ON IMMUNE CELL POPULATIONS
#183METHODS OF ASSESSING CELL PRODUCTS
#184HIGHLY SENSITIVE AND SPECIFIC LUCIFERASE BASED REPORTER ASSAY FOR ANTIGEN DETECTION
#185METHOD FOR DETECTING ANTI-CAR ANTIBODY AGAINST HUMANIZED CART CELLS
#186KIR3DL2 BINDING AGENTS
#187Polymer Composite Nanomaterial Encapsulation System
#188METHODS AND COMPOSITIONS RELATED TO T-CELL ACTIVITY
#189B-CELL MATURATION ANTIGEN (BCMA) ANTI-IDIOTYPIC ANTIBODIES
#190EPHA2 T-CELL EPITOPE AGONISTS AND USES THEREFORE
#191NOVEL ESR1 DERIVED PEPTIDES AND USES THEREOF FOR NEOANTIGEN THERAPY
#192PERIPHERAL BLOOD PHENOTYPE LINKED TO OUTCOMES AFTER IMMUNOTHERAPY TREATMENT
#193IMPROVED TREATMENT METHODS USING DMDS FOR THE TREATMENT OF AUTOIMMUNE DISEASES, AND BIOMARKER FOR PREDICTING AND/OR OPTIMISING SAID TREATMENT METHODS
#194Methods for producing genetically engineered cell compositions and related compositions
#195DISPLAY OF PEPTIDE-MHC (PMHC) ON MULTIMERIC PROTEIN SCAFFOLDS AND USES THEREOF
#196Blood Preparation and Profiling
#197COMPOSITIONS FOR DETECTING SECRETION AND METHODS OF USE
#198METHODS OF SELECTIVELY TARGETING CD6 HIGH CELLS AND DECREASING ACTIVITY OF TEFF CELLS
#199COMPOSITIONS AND METHODS FOR SINGLE CELL ANALYTE DETECTION AND ANALYSIS
#200T CELL RECEPTORS AND PEPTIDES DERIVED BY MUTATIONS FOR THE TREATMENT OF CANCER
#201METHOD FOR GENERATING HIGH AFFINITY ANTIBODIES
#202HIGH PARAMETER REAGENT PANEL AND REAGENT KIT FOR EFFECTIVE DETECTION OF ABERRANT CELLS IN ACUTE MYELOID LEUKEMIA
#203B CELL MONITORING REAGENT PANEL AND REAGENT KIT FOR ANALYZING B CELL SUBSETS IN ANTI-CD20 TREATED AUTOIMMUNE PATIENTS
#204METHODS AND APARATUS FOR A MOUSE SURFACE AND INTRACELLULAR FLOW CYTOMETRY IMMUNOPHENOTYPING KIT
#205METHODS FOR THE DIAGNOSIS AND THE TREATMENT OF GRAFT-VERSUS-HOST DISEASE
#206ADDITIVES FOR REDUCING NON-SPECIFIC INTERACTIONS BETWEEN FLUORESCENT POLYMER CONJUGATES AND CELLS IN A BIOLOGICAL SAMPLE
#207METHODS FOR DIAGNOSIS AND MONITORING OF TOXIC EPIDERMAL NECROLYSIS
#208ANTIBODY-LINKED IMMUNO-SEDIMENTATION AGENT AND METHOD OF ISOLATING A TARGET FROM A SAMPLE USING SAME
#209DYSFUNCTIONAL ANTIGEN-SPECIFIC CD8+ T CELLS IN THE TUMOR MICROENVIRONMENT
#210METHODS OF IDENTIFYING GAMMA DELTA T CELL-MODULATING AGENTS
#211SINGLE-CELL COMBINATORIAL INDEXED CYTOMETRY SEQUENCING
#212DEVICES AND METHODS OF CELL CAPTURE AND ANALYSIS
#213FLOW BASED ASSAYS FOR THERAPEUTICS
#214METHOD FOR DETECTING IMMUNE EFFICACY AND METHOD OF TREATING A CANCER
#215SARS-COV-2 IMMUNODOMINANT PEPTIDE CONSTRUCTS AND USES THEREOF
#216METHODS AND COMPOSITIONS FOR CANCER IMMUNOTHERAPY
#217IMPROVED DETECTION OF LYMPHOCYTE - TARGET CELL INTERACTION
#218NOVEL T CELLS AND THE USES THEREOF
#219Methods For Identification of Cognate Pairs of Ligands and Receptors
#220NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS
#221COMPOSITIONS AND METHODS FOR EARLY DETECTION OF OSTEOPOROSIS
#222Diabetes Biomarkers
#223ANTI-IDIOTYPIC ANTIBODIES TO ROR1-TARGETED BINDING DOMAINS AND RELATED COMPOSITIONS AND METHODS
#224Antibody composition for immunotyping of myeloid tumor and use thereof
#225BAT ASSAYS FOR IN VITRO DETERMINATION OF ALLERGIC REACTION
#226TOLEROGENIC SYNTHETIC NANOCARRIERS TO REDUCE IMMUNE RESPONSES TO THERAPEUTIC PROTEINS
#227TOLEROGENIC SYNTHETIC NANOCARRIERS TO REDUCE ANTIBODY RESPONSES
#228Method and system for buoyant-particle-assisted cell therapy
#229TOLEROGENIC SYNTHETIC NANOCARRIERS FOR ALLERGY THERAPY
#230AUTOMATED SAMPLE PREPARATION PLATFORM FOR CELLULAR ANALYSIS
#231MONOCYTE
#232Biomarkers for Identifying Relapses in Multiple Sclerosis
#233SAMPLE ANALYSIS METHOD, SAMPLE ANALYZER, AND COMPUTER-READABLE STORAGE MEDIUM
#234METHOD FOR LABELING INTRACELLULAR AND EXTRACELLULAR TARGETS OF LEUKOCYTES
#235IDENTIFICATION OF LOW-DENSITY INFLAMMATORY NEUTROPHILS IN SEVERE COVID-19 PATIENTS
#236CD127 EXPRESSION INVERSELY CORRELATES WITH FOXP3 AND SUPPRESSIVE FUNCTION OF CD4+ TREGS
#237METHOD OF PREPARING A MEASUREMENT SPECIMEN AND SPECIMEN PREPARATION APPARATUS
#238Methods and Compositions for Diagnosing and Treating Cancer
#239METHODS AND SYSTEM FOR VALIDATING FLOW CYTOMETRY MEASUREMENTS
#240MAGEA1 IMMUNOGENIC PEPTIDES, BINDING PROTEINS RECOGNIZING MAGEA1 IMMUNOGENIC PEPTIDES, AND USES THEREOF
#241PREDICTING IMMUNOTHERAPY RESPONSE
#242MICROSCOPIC DETECTION OF BLAST-TRANSFORMED MONONUCLEAR CELLS
#243Adult stem cell compositions and methods of identification and isolation
#244NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS
#245HYDROGEL MICROPARTICLES FOR APPLICATIONS IN CELL AND PARTICLE SEPARATION
#246T CELL PHENOTYPES ASSOCIATED WITH RESPONSE TO ADOPTIVE CELL THERAPY
#247BREAST CANCER BIOMARKERS AND METHODS OF USE
#248ADAPTIVE NANOPARTICLE PLATFORMS FOR HIGH THROUGHPUT EXPANSION AND DETECTION OF ANTIGEN-SPECIFIC T CELLS
#249METHODS FOR PREDICTING THE RISK OF RECURRENCE AND/OR DEATH OF PATIENTS SUFFERING FROM A SOLID CANCER AFTER PREOPERATIVE ADJUVANT THERAPIES
#250PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS
#251PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS
#252PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS
#253T CELL RECEPTOR (TCR) COMPOSITIONS AND METHODS FOR OPTIMIZING ANTIGEN REACTIVE T-CELLS
#254NEW ANTIBODY BLOCKING HUMAN FCGRIIIA AND FCGRIIIB
#255METHOD FOR EVALUATING THE METABOLIC ACTIVITY OF A NON-CANCER CELL
#256T CELL SPECIFIC BIOMARKERS FOR PREDICTING GRAFT-VS-HOST DISEASE AND HEMATOPOIETIC MALIGNANCY RELAPSE FOLLOWING HEMATOPOIETIC STEM CELL TRANSPLANTATION AND TREATMENT THEREOF
#257ESTIMATING CELLULAR POPULATIONS
#258USE OF AUTOMATED PLATFORMS FOR PREPARATION OF BIOMARKER AND ROMANOWSKY-TYPE STAINED SAMPLE PRINTED ON A SLIDE
#259DEVICE OR METHOD FOR DETECTION OF LEUKOCYTE IN DISEASE STATE OR FOR DIAGNOSIS OF LEUKOCYTE-RELATED DISEASE
#260Methods for isolating target cells from blood
#261Neutrophil Progenitors and Related Methods and Uses
#262FORMULATION FOR TOTAL AND DIFFERENTIAL COUNTING OF LEUKOCYTES IN LIQUID MEDIUM AND METHOD OF MAKING AND USING SAME
#263Immune Cell Biomarkers of Cardiovascular Disease
#264CELLS FOR TREATING CANCER
#265NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS
#266Stem Cell Memory T Cells, Methods and Uses for Modulating Inflammatory Responses, and Diagnosing and Treating Adverse Cardiovascular Events and Disease
#267Methods for isolating, culturing, and genetically engineering immune cell populations for adoptive therapy
#268ENGINEERED CELLS EXPRESSING PROSTATE-SPECIFIC MEMBRANE ANTIGEN (PSMA) OR A MODIFIED FORM THEREOF AND RELATED METHODS
#269Method of Identifying Pro-Inflammatory Dendritic Cells
#270Polypeptide for targeting recognition of immune cells and application thereof
#271METHOD OF EXTRACORPOREAL PHOTOPHERESIS FOR IMMUNE-RELATED ADVERSE EVENTS
#272COMPOSITIONS AND METHODS FOR DIAGNOSING NARCOLEPSY
#273STRATEGIES TO ASSESS AND/OR PRODUCE CELL POPULATIONS WITH PREDICTIVE ENGRAFTMENT POTENTIAL
#274NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS
#275HIGH THROUGHPUT EPITOPE IDENTIFICATION AND T CELL RECEPTOR SPECIFICITY DETERMINATION USING LOADABLE DETECTION MOLECULES
#276METHOD FOR DETECTION OF CD16B
#277METHODS AND COMPOSITIONS FOR ASSESSING IMMUNE RESPONSE IN MURINE TUMOR MODELS
#278NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS
#279NOVEL COMPOSITIONS AND METHODS FOR THE TREATMENT OF IMMUNE RELATED DISEASES
#280MULTISPECIFIC ANTIBODIES AGAINST CD40 AND CD137
#281NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS
#282NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS
#283MONOLAYER OF PBMCS OR BONE-MARROW CELLS AND USES THEREOF
#284BIOMARKER TEST AND METHOD FOR ASSESSING MUCOSAL HEALING IN RESPONSE TO TREATMENT OF ULCERATIVE COLITIS
#285NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS
#286SINGLE CHAIN TRIMER MHC CLASS II NUCLEIC ACIDS AND PROTEINS AND METHODS OF USE
#287METHOD FOR PREDICTING PATIENT RESPONSE TO IMMUNOTHERAPY
#288CYTOMETRIC ASSAYS
#289SELECTION OF PATIENTS FOR COMBINATION THERAPY
#290CELLULAR PLATFORM FOR RAPID AND COMPREHENSIVE T-CELL IMMUNOMONITORING
#291CD8+T-CELL SUBSETS AS MARKERS FOR PREDICTION OF DELAYED FRACTURE HEALING
#292AN IN VITRO KIT AND A METHOD FOR DIAGNOSTICS IN TRANSPLANTS AND/OR AUTOIMMUNE DISEASES AND/OR TUMOR DISEASES AND/OR VACCINATIONS AND A MESSENGER-SUBSTANCE-CONTAINING SUPERNATANT, CELL-CONTAINING SEDIMENT, AND A COMBINATION, FOR USE IN DIAGNOSTICS IN TRANSPLANTS AND/OR AUTOIMMUNE DISEASES AND/OR TUMOR DISEASES AND/OR VACCINATIONS
#293METHOD OF DERIVING A VALUE FOR PERCENT BIOMARKER POSITIVITY FOR SELECTED CELLS PRESENT IN A FIELD OF VIEW
#294PIF BINDING AS A MARKER FOR IMMUNE DYSREGULATION
#295TESTING AND REPRESENTING SUSPICION OF SEPSIS
#296METHODS OF ANALYSIS OF BLOOD FROM DECEASED DONORS
#297Antigen binding molecules specific for an anti-CD19 scFV
#298BIOMARKERS OF EARLY OSTEOARTHRITIS
#299MEANS AND METHODS FOR MULTIPARAMETER CYTOMETRY-BASED LEUKOCYTE SUBSETTING
#300TCR-INDEPENDENT MOLECULAR IDENTIFICATION OF MUTATION-RELATED AND TUMOR-SPECIFIC T CELLS